Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG

Track this case

Case Number:

IPR2020-01317

Case Type:

IPR

Status:

Institution Denied

Petitioner:

Regeneron Pharmaceuticals, Inc.

Patent Owner:

Novartis Pharma AG

Tech Center:

3700

  1. Filed: July 16, 2020 00:00

    Coverage

    1. January 19, 2021

      PTAB Denies Bid To Review Eye Shot Patent, Citing ITC Case

      The Patent Trial and Appeal Board has refused to review a Novartis Pharma AG patent covering a syringe meant for eye injections, citing the "advanced stage" of a parallel case involving the same parties before the U.S. International Trade Commission.


    Stay ahead of the curve

    In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


    • Search PTAB cases and full-text documents.
    • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
    • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

    TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!